| Schedule of Computation of Basic and Diluted Net Loss per Share |
The following table sets forth the computation of the Company’s basic and diluted net loss per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
June 30, |
|
|
Six Months Ended
June 30, |
|
|
|
2026 |
|
|
2025 |
|
|
2026 |
|
|
2025 |
|
Numerator: |
|
|
|
|
|
|
|
|
|
|
|
|
Net loss |
|
$ |
(54,799 |
) |
|
$ |
(39,480 |
) |
|
$ |
(111,536 |
) |
|
$ |
(78,762 |
) |
Denominator: |
|
|
|
|
|
|
|
|
|
|
|
|
Shares used to compute net loss per share, basic and
diluted |
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares of common stock
outstanding |
|
|
99,280,401 |
|
|
|
77,539,468 |
|
|
|
92,728,853 |
|
|
|
67,476,597 |
|
Weighted average shares of pre-funded warrants to
purchase common stock |
|
|
44,408,300 |
|
|
|
16,600,818 |
|
|
|
34,114,812 |
|
|
|
12,840,991 |
|
Weighted average shares of common stock
outstanding used to compute basic and diluted
net loss per share |
|
|
143,688,701 |
|
|
|
94,140,286 |
|
|
|
126,843,665 |
|
|
|
80,317,588 |
|
Net loss per share, basic and diluted |
|
$ |
(0.38 |
) |
|
$ |
(0.42 |
) |
|
$ |
(0.88 |
) |
|
$ |
(0.98 |
) |
|
| Schedule of Antidilutive Securities Excluded from Computation of Diluted Net Loss |
|
|
|
|
|
|
|
|
|
|
|
As of June 30, |
|
|
|
2026 |
|
|
2025 |
|
Options to purchase common stock |
|
|
6,724,162 |
|
|
|
3,324,305 |
|
Nonvested restricted stock units |
|
|
5,590,513 |
|
|
|
3,102,124 |
|
Nonvested performance stock units |
|
|
1,689,025 |
|
|
|
2,074,188 |
|
Shares subject to employee stock purchase plan |
|
|
235,127 |
|
|
|
216,802 |
|
Warrants |
|
|
2,000 |
|
|
|
2,563 |
|
Total |
|
|
14,240,827 |
|
|
|
8,719,982 |
|
|